In collaboration with engineers and microfluidics experts, we develop a novel ex vivo brain tumor research platform for investigating molecular effectors of brain tumor cell growth and invasiveness and for evaluating drug effects on the targeted tumor cells and the surrounding brain tissue. With this entirely novel approach, we also develop a valuable, physiologically relevant pre-clinical research tool to reduce the number of animals used in pre-clinical cancer research (3R).